Login
$ROIV
$36.54 +$0.49 (1.36%) Close

$ROIV SEC Filings

Filed On Filing
27 Oct 2026 SCHEDULE 13G/A
22 Oct 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 200,000 shares ($7.02M)

21 Oct 2026 8-K: Regulation FD Disclosure

Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)

20 Oct 2026 Form 4: Sukhatme Mayukh, Director

Gave up 19,976 shares to cover exercise price or tax ($670K)

20 Oct 2026 Form 4: Gline Matthew, Director

Gave up 34,638 shares to cover exercise price or tax ($1.16M)

20 Oct 2026 144
05 Oct 2026 Form 4: Epperly Melissa B,, Director

Received 17,750 shares by exercise or conversion ($79.2K) · Sold 17,750 shares ($641K)

05 Oct 2026 SCHEDULE 13D/A
05 Oct 2026 Form 4: Roivant Sciences Ltd., Director · Arbutus Biopharma Corp

Returned 8,967,383 shares to the issuer ($44.8M)

02 Oct 2026 Form 4: Sukhatme Mayukh, Director

Gave up 46,879 shares to cover exercise price or tax ($1.71M)

02 Oct 2026 Form 4: Venker Eric, President & Immunovant CEO

Received 200,000 shares by exercise or conversion ($770K) · Sold 200,000 shares ($7.32M)

02 Oct 2026 Form 4: Gline Matthew, Director

Gave up 76,171 shares to cover exercise price or tax ($2.79M)

02 Oct 2026 Form 4: Torti Frank, President and Vant Chair

Acquired 40,309 shares (Exercise Price / Tax Payment) ($1.47M)

30 Sep 2026 144
22 Sep 2026 Form 4: Pulik Richard, CFO

Gave up 2,129 shares to cover exercise price or tax ($84.7K)

22 Sep 2026 Form 4: Humes Jennifer, Chief Accounting Officer

Gave up 3,880 shares to cover exercise price or tax ($154K)

18 Sep 2026 Form 4: Gold Daniel Allen, Director

Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)

18 Sep 2026 Form 4: Oren Ilan, Director

Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)

18 Sep 2026 Form 4: Manchester Keith S, Director

Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)

18 Sep 2026 Form 4: Epperly Melissa B,, Director

Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support